Evotec · 2 months ago
SVP, Finance, Biologics & US Country Lead
Seattle, WA
Full-time
Hybrid
Director/Executive
$250K/yr - $300K/yrEvotec is a forward-thinking team committed to innovation and success. They are looking for a passionate SVP, Finance, Biologics & US Country Lead to drive impactful projects, collaborate with teams globally, and provide financial oversight for U.S. operations.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Partner with commercial leadership across regions to analyze sales performance, monitor KPIs, and identify revenue growth opportunities
Deliver data-driven insights on the financial impact of sales strategies and go-to-market initiatives globally
Support accurate and timely forecasting by combining historical data, sales pipelines, and international market intelligence
Lead margin optimization strategies through strategic pricing initiatives and new business models
Collaborate with Operations and Supply Chain functions globally to implement sustainable cost-saving measures
Conduct regular COGS reviews and gross margin analysis at product/service levels
Drive OPEX efficiency and assess ROI of strategic investments
Develop and refine pricing models that reflect global market dynamics and profitability goals
Monitor international pricing trends, input costs, and competitive positioning
Provide actionable financial insights to regional Sales and Marketing leaders
Oversight of all Finance and Accounting activities for the US entities including Just-Evotec Biologics, Inc. in close alignment with Group Accounting and FP&A
Support local controlling on entity-level financial governance, including audits, intercompany transactions, and cash management
Represent Finance in U.S. leadership discussions and act as the key liaison between U.S. operations and global Finance
Provide oversight of U.S. budgeting, forecasting, and performance tracking within the broader global framework
Serve as the financial liaison between corporate finance and operational teams
Lead and participate in global planning, budgeting, and forecasting processes
Co-lead monthly performance reviews with local and regional management teams
Oversee preparation of financial reports and dashboards for executive leadership
Provide analysis and commentary on actual vs. budgeted performance across business units and regions
Ensure transparency and consistency in global reporting, adhering to international accounting standards
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or related field
Familiarity with IFRS required
Substantial leadership experience in financial planning & analysis, business partnering, or corporate finance
Significant experience in multinational environments, ideally within life sciences, biotech, or biologics industries
Deep knowledge of global finance, cost structures, and international margin management
Proficiency in ERP systems (e.g., SAP) and BI tools (e.g., Power BI, Tableau)
Exceptional communication and stakeholder management skills across geographies
Strategic mindset with operational discipline and hands-on execution capability
Preferred
MBA or relevant Master's degree
U.S. GAAP and SEC reporting experience is a plus
CPA, CFA, or CIMA designation highly desirable
Fluency in French, German, or Italian is an asset
Benefits
Discretionary annual bonus
Comprehensive benefits to include Medical, Dental and Vision
Short-term and long-term disability
Company paid basic life insurance
401k company match
Flexible work
Generous paid time off
Paid holiday
Wellness and transportation benefits
Company
Evotec
Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.
Founded in 1993
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$746.74MKey Investors
Bill & Melinda Gates FoundationKorea Advanced Institute of Science and TechnologyOpen Philanthropy
2025-05-07Grant· $2.5M
2025-01-22Grant
2023-12-19Grant· $2.5M
Leadership Team
Christian Wojczewski
CEO
Claudia Karnbach
EVP, Global Head of Partnerships and Alliances
Recent News
2026-01-07
Company data provided by crunchbase